RH

Rangappa Hariharappanapalya Nayana

Active Director Director DIN 11775911
DIN 11775911 First appointment Jun 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Rangappa Hariharappanapalya Nayana

Rangappa Hariharappanapalya Nayana is a Director at Advitha Pet Hospital Private Limited (since 2026).

DIN 11775911
Primary Designation Director
First Appointment 18 Jun 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Advitha Pet Hospital Private Limited U86100KA2026PTC222527
Director18 Jun 20262026Active

Board colleagues of Rangappa Hariharappanapalya Nayana

NameDINCompanyDesignation
Vasanthaiah Seegepalya Bharath Raj11775912Advitha Pet Hospital Private LimitedDirector/Designated Partner

Directorship timeline

Open interactive timeline →
Advitha Pet Hospital Private Limited
Premium access

Shareholding and investment profile for Rangappa Hariharappanapalya Nayana

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rangappa Hariharappanapalya Nayana

Rangappa Hariharappanapalya Nayana currently holds 1 directorship: Advitha Pet Hospital Private Limited (Director, since 18 Jun 2026).

Rangappa Hariharappanapalya Nayana was first appointed on 18 Jun 2026 as Director at Advitha Pet Hospital Private Limited.

The current boards of Rangappa Hariharappanapalya Nayana's companies include Vasanthaiah Seegepalya Bharath Raj (Advitha Pet Hospital Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available